Skip to main content
. Author manuscript; available in PMC: 2012 Nov 25.
Published in final edited form as: J Mol Cell Cardiol. 2005 Oct 19;39(6):865–873. doi: 10.1016/j.yjmcc.2005.09.007

Fig. 6.

Fig. 6

Stimulation of human ES cell-derived cardiomyocyte proliferation. H7 human ES cells were differentiated for 17 days before Percoll separation, and fraction IV cells were cultured for an additional 4 days in serum-free media. Various concentrations of recombinant human IGF-1 or IGF-2 were added for the final 48 hours of culture prior to fixation. IGFs increased cardiomyocyte proliferation in a dose-dependent manner to levels greater than treatment with 20% FBS (* = P < 0.05).

HHS Vulnerability Disclosure